AQR Capital Management’s Korro Bio KRRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.03M Buy
267,755
+227,108
+559% +$2.5M ﹤0.01% 2077
2025
Q4
$326K Sell
40,647
-7,760
-16% -$181K ﹤0.01% 3134
2025
Q3
$2.32M Buy
+48,407
New +$1.07M ﹤0.01% 1893
2022
Q3
Sell
-2,016
Closed -$151K 2260
2022
Q2
$151K Buy
2,016
+1,432
+245% +$96.8K ﹤0.01% 2033
2022
Q1
$62K Buy
+584
New +$112K ﹤0.01% 2176

Other funds holding KRRO

AQR Capital Management's KRRO Position: Q1 2026 in Review

AQR Capital Management increased its Korro Bio (KRRO) stake by 559% in Q1 2026, buying an estimated $2.5M and bringing the position to 267,755 shares worth $3.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

AQR Capital Management first reported a position in KRRO in Q1 2022 and has held it in 5 quarters since. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • AQR Capital Management held 267,755 shares of Korro Bio worth $3.03M as of Q1 2026.
  • AQR Capital Management bought 227,108 Korro Bio shares in Q1 2026, an estimated $2.5M.
  • Korro Bio made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2077 holding.
  • AQR Capital Management first reported a position in Korro Bio in Q1 2022 and has held it in 5 quarters since.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.